My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Jubilant Life Sciences slips after hiking prices of select products
Dec 20,2016

The announcement was made during trading hours today, 20 December 2016.

Meanwhile, the BSE Sensex was down 66.47 points, or 0.25%, to 26,308.23.

On the BSE, so far 93,000 shares were traded in the counter, compared with average daily volumes of 1.52 lakh shares in the past one quarter. The stock had hit a high of Rs 626.75 and a low of Rs 595 so far during the day.

The stock hit a record high of Rs 726.40 on 1 December 2016. The stock hit a 52-week low of Rs 272.50 on 20 January 2016. The stock had underperformed the market over the past 30 days till 19 December 2016, falling 1.44% compared with the 0.86% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 5.02% as against Sensexs 7.53% decline.

The mid-cap company has equity capital of Rs 15.93 crore. Face value per share is Re 1.

Jubilant Life Sciences announced a price increase of up to 15% for its Beta Picoline, 3-Cyanopyridine and vitamin B3 (Niacin & Niacinamide) with immediate effect, for non-contract customers and wherever existing contracts permit.

On a consolidated basis, net profit of Jubilant Life Sciences rose 14.52% to Rs 144.77 crore on 5.16% decline in net sales to Rs 1359.70 crore in Q2 September 2016 over Q2 September 2015.

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in pharmaceuticals, life science ingredients and drug discovery solutions.

Powered by Capital Market - Live News

Bajaj Hindusthan Sugar gains on plan to sell co-gen power operation
Dec 20,2016

The announcement was made during trading hours today, 20 December 2016.

Meanwhile, the BSE Sensex was down 42.41 points, or 0.16%, to 26,332.29.

On the BSE, so far 11.81 lakh shares were traded in the counter, compared with average daily volumes of 3.41 lakh shares in the past one quarter. The stock had hit a high of Rs 14.74 and a low of Rs 13.05 so far during the day.

The stock hit a 52-week high of Rs 24.20 on 13 June 2016. The stock hit a 52-week low of Rs 12.65 on 12 February 2016. The stock had underperformed the market over the past 30 days till 19 December 2016, falling 10.27% compared with the 0.86% rise in the Sensex. The scrip had also underperformed the market in past one quarter, falling 24.03% as against Sensexs 7.53% decline.

The small-cap company has equity capital of Rs 113.36 crore. Face value per share is Re 1.

Bajaj Hindusthan Sugar said that the board of directors of the company at its meeting held on 20 December 2016, considered approval of sale and transfer of co-generation power business of aggregating capacity of 449 megawatts (MW) located at 14 locations to Lalitpur Power Generation Company (LPGCL), a group company for a lumpsum consideration in cash of approximately Rs 1800 crore, as a going concern on slump sale basis in accordance with the business transfer agreement to be entered into with LPGCL.

Entire amount of cash consideration is proposed to be utilised by Bajaj Hindusthan Sugar towards advance repayment of its existing term debt. The proposed sale and transfer of co-generation power business will be subject to approval of members, lenders and all other statutory /regulatory authorities, the company said in a statement.

Bajaj Hindusthan Sugar reported net loss of Rs 137.71 crore in Q2 September 2016 as against net loss of Rs 280.17 crore in Q2 September 2015. Net sales rose 13% to Rs 850.08 crore in Q2 September 2016 over Q2 September 2015.

Bajaj Hindusthan Sugar is a sugar and ethanol manufacturing company.

Powered by Capital Market - Live News

Mercator advances after new order win
Dec 20,2016

The period of contract is four years (inclusive of charterers options) and the charter will commence from January 2017. The announcement was made during market hours today, 20 December 2016.

Meanwhile, the S&P BSE Sensex was down 91.42 points or 0.35% at 26,283.28

On the BSE, 4.15 lakh shares were traded on the counter so far as against average daily volumes of 4.59 lakh shares in the past one quarter. The stock hit a high of Rs 41 and a low of Rs 38 so far during the day. The stock had hit a 52-week high of Rs 54.55 on 6 September 2016. The stock had hit a 52-week low of Rs 15.90 on 12 February 2016. The stock had outperformed the market over the past 30 days till 19 December 2016, rising 4.39% compared with the 0.86% rise in the Sensex. The scrip, however, underperformed the market in past one quarter, sliding 22.98% as against Sensexs 7.53% decline.

The small-cap company has equity capital of Rs 24.49 crore. Face value per share is Re 1.

Mercator reported net loss of Rs 26.47 crore in Q2 September 2016 compared with net profit of Rs 14.57 crore in Q2 September 2015. Net sales declined 19.58% to Rs 133.28 crore in Q2 September 2016 over Q2 September 2015.

Mercator group has business interests in coal, oil & gas, shipping and dredging.

Powered by Capital Market - Live News

FACT, GSFC correct on profit booking
Dec 20,2016

Gujarat State Fertilizers & Chemicals (GSFC) (down 2.46% to Rs 93.20) and Fertilizers and Chemicals Travancore (FACT) (down 1.46% to Rs 23.70), edged lower.

The S&P BSE Sensex was down 125.84 points, or 0.48% at 26,248.86.

Shares of FACT rose 4.34% to settle at 24.05 and shares of GSFC jumped 8.95% to settle at 95.55 yesterday, 19 December 2016, after media reports suggested that prices of caprolactam hit a two-year high.

According to media reports, Asian caprolactam hit a 2-year high on Thursday, 15 December 2016, with the CFR Far East Asia marker assessed by S&P Global Platts at $1,830 per metric tonne. The last time the price was at this level was on 18 December 2014, when the Platts CFR Far East Asia marker was assessed at $1,900 a metric tonne.

Caprolactam, a derivative of benzene, is used for manufacturing nylon, tyre-cord, textile filament yarn and engineering plastics.

GSFC and FACT are two major manufacturers of caprolactam in India. GSFC has two caprolactam plants having rated capacities of 20,000 tonnes per annum (TPA) and 50,000 TPA. Meanwhile, FACT has the capacity to produce 50,000 tonnes of caprolactam in a year. FACT exports caprolactam to various countries, including the US.

Powered by Capital Market - Live News

Volumes jump at India Gelatine & Chemicals counter
Dec 20,2016

India Gelatine & Chemicals clocked volume of 17.46 lakh shares by 13:29 IST on BSE, a 1401.42-times surge over two-week average daily volume of 1,246 shares. The stock surged 8.13% to Rs 71.15.

Narayana Hrudayalaya notched up volume of 7.92 lakh shares, a 267.87-fold surge over two-week average daily volume of 3,000 shares. The stock shed 0.87% to Rs 334.90.

Prism Cement saw volume of 24.47 lakh shares, a 155.45-fold surge over two-week average daily volume of 16,000 shares. The stock fell 0.72% to Rs 82.20.

HSIL clocked volume of 3.04 lakh shares, a 44-fold surge over two-week average daily volume of 7,000 shares. The stock fell 0.07% to Rs 280.15.

InterGlobe Aviation saw volume of 2.30 lakh shares, a 19.92-fold rise over two-week average daily volume of 12,000 shares. The stock rose 0.13% to Rs 833.

Powered by Capital Market - Live News

Siti Networks advances after large bulk deal
Dec 20,2016

Meanwhile, the S&P BSE Sensex was down 66.38 points or 0.25% at 26,308.32

Bulk deal boosted volume on the scrip. On the BSE, 1.47 crore shares were traded on the counter so far as against average daily volumes of 2.88 lakh shares in the past one quarter. The stock had hit a high of Rs 41.35 and a low of Rs 36.50 so far during the day. The stock had hit a 52-week high of Rs 41.70 on 5 January 2016. The stock had hit a 52-week low of Rs 30.90 on 12 February 2016. The stock had outperformed the market over the past 30 days till 19 December 2016, rising 4.83% compared with the 0.86% rise in the Sensex. The scrip also outperformed the market in past one quarter, gaining 6.8% as against Sensexs 7.53% decline.

The small-cap company has equity capital of Rs 79.41 crore. Face value per share is Re 1.

On a consolidated basis, Siti Networks reported net loss of Rs 46.89 crore in Q2 September 2016, higher than net loss of Rs 31.43 crore in Q2 September 2015. Net sales rose 23.4% to Rs 285.26 crore in Q2 September 2016 over Q2 September 2015.

Siti Networks is one of Indias largest multi system operator (MSO). The company provides its cable services in Indias 250 plus cities and the adjoining areas.

Powered by Capital Market - Live News

Bharat Financial Inclusion tops losers on BSEs A group
Dec 20,2016

Bharat Financial Inclusion slipped 4.48% at Rs 576.60. The stock topped the losers in A group. On the BSE, 4.32 lakh shares were traded on the counter so far as against the average daily volumes of 1.54 lakh shares in the past two weeks.

Unitech slipped 4.31% at Rs 4.22. The stock was the second biggest loser in A group. On the BSE, 28.84 lakh shares were traded on the counter so far as against the average daily volumes of 27.56 lakh shares in the past two weeks.

Allahabad Bank slipped 4.02% at Rs 63.35. The stock was the third biggest loser in A group. On the BSE, 1.44 lakh shares were traded on the counter so far as against the average daily volumes of 1.83 lakh shares in the past two weeks.

Page Industries slipped 4.08% at Rs 13,408.65. The stock was the fourth biggest loser in A group. On the BSE, 434 shares were traded on the counter so far as against the average daily volumes of 980 shares in the past two weeks.

Jaiprakash Associates slipped 3.88% at Rs 7.43. The stock was the fifth biggest loser in A group. On the BSE, 14.48 lakh shares were traded on the counter so far as against the average daily volumes of 20.02 lakh shares in the past two weeks.

Powered by Capital Market - Live News

Welspun Enterprises spurts on buyback plan
Dec 20,2016

The announcement was made after market hours hours yesterday, 19 December 2016.

Meanwhile, the BSE Sensex was down 65.63 points, or 0.25%, to 26,309.07.

On the BSE, so far 2.70 lakh shares were traded in the counter, compared with average daily volumes of 1.36 lakh shares in the past one quarter. The stock had hit a high of Rs 66.65 and a low of Rs 59.55 so far during the day.

The stock hit a 52-week high of Rs 75.30 on 3 November 2016. The stock hit a 52-week low of Rs 43 on 12 February 2016. The stock had outperformed the market over the past 30 days till 19 December 2016, rising 1.28% compared with the 0.86% rise in the Sensex. The scrip had also outperformed the market in past one quarter, falling 5.70% as against Sensexs 7.53% decline.

The small-cap company has equity capital of Rs 174.28 crore. Face value per share is Rs 10.

Net profit of Welspun Enterprises rose 116.67% to Rs 2.86 crore on 16.93% rise in net sales to Rs 33.22 crore in Q2 September 2016 over Q2 September 2015.

Welspun Enterprises key activity is in the infrastructure business. The company has executed infrastructure projects such as highways, bridges, industrial, residential and commercial buildings.

Powered by Capital Market - Live News

8K Miles Software jumps on acquisition of US firm
Dec 20,2016

The announcement was made during market hours today, 20 December 2016.

Meanwhile, the S&P BSE Sensex was down 85.45 points or 0.32% at 26,289.25.

On the BSE, 26,000 shares were traded on the counter so far as against the average daily volumes of 10,047 shares in the past one quarter. The stock had hit a high of Rs 701.90 and a low of Rs 651 so far during the day.

The stock had a hit record high of Rs 956.25 on 14 January 2016 and a 52-week low of Rs 478.13 on 12 Febraury 2016. The stock had underperformed the market over the past one month till 19 December 2016, declining 1.43% compared with the Sensexs 0.86% rise. The scrip had also underperformed the market over the past one quarter declining 9.92% as against the Sensexs 7.89% fall.

The small-cap company has equity capital of Rs 15.26 crore. Face value per share is Rs 5.

8K Miles Software Services announced that its US-subsidiary 8K Miles Software Services, Inc has entered into a definitive Agreement to acquire Cornerstone Advisors Group, LLC (Cornerstone), a leading US healthcare information technology company, for $10,250,000 inclusive of earn-out payments as a combination of cash and stock from the 8K Miles US-subsidiary.

Once completed, the acquisition of Cornerstone will further strengthen 8K Miles position as a partner, consultant and technology solution provider to healthcare clients in the US.

Suresh Venkatachari, Chairman & CEO of 8K Miles said that with the acquisition of Cornerstone, the company will add more than 50 top healthcare experts, consultants and practice directors in the US. Also, this acquisition strengthens 8k Miles position as a thought leader in healthcare information technology services.

This acquisition is subject to customary closing conditions and is expected to close in Q4 March 2017.

8K Miles Software Services consolidated net profit rose 22.24% to Rs 23.63 crore on 17.62% growth in net sales to Rs 122.18 crore in Q2 September 2016 over Q1 June 2016.

8K Miles Software Services is a leading global IT business transformation, secure cloud solutions and managed services company.

Powered by Capital Market - Live News

The Phoenix Mills gains on plan to hike stake in subsidiary
Dec 20,2016

The announcement was made after market hours yesterday, 19 December 2016.

Meanwhile, the BSE Sensex was down 71.49 points, or 0.27%, to 26,303.21.

On the BSE, so far 566 shares were traded in the counter, compared with average daily volumes of 2,516 shares in the past one quarter. The stock had hit a high of Rs 376 and a low of Rs 366.85 so far during the day.

The stock hit a 52-week high of Rs 445 on 8 September 2016. The stock hit a 52-week low of Rs 238.30 on 29 February 2016. The stock had outperformed the market over the past 30 days till 19 December 2016, rising 8.63% compared with the 0.86% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, falling 14.11% as against Sensexs 7.53% decline.

The mid-cap company has equity capital of Rs 30.61 crore. Face value per share is Rs 2.

The Phoenix Mills entered into a share purchase agreement for acquisition of the entire 15.18% stake in its subsidiary Offbeat Developers (ODPL) held by Vistra ITCL (India) and IIRF Holdings X. Further, the company has entered into a share purchase agreement to acquire Eder Rivers entire 4.98% stake in ODPL. Subsequent to the completion of both the aforesaid transactions, the shareholding of The Phoenix Mills in ODPL will increase from 74.48% to 94.64%.

On a consolidated basis, net profit of Phoenix Mills rose 41.98% to Rs 54.28 crore on 16.22% rise in net sales to Rs 491.08 crore in Q2 September 2016 over Q2 September 2015.

The Phoenix Mills focuses on real estate development and entertainment.

Powered by Capital Market - Live News

Granules India drops as USFDA completes inspection of Vizag unit
Dec 20,2016

The announcement was made after market hours yesterday, 19 December 2016.

Meanwhile, the S&P BSE Sensex was up 27.33 points or 0.1% at 26,402.03

On the BSE, 70,000 shares were traded on the counter so far as against the average daily volumes of 1.59 lakh shares in the past one quarter. The stock had hit a high of Rs 113.80 and a low of Rs 111.30 so far during the day. The stock had hit a 52-week high of Rs 161.35 on 21 December 2015. The stock had hit a 52-week low of Rs 91.45 on 9 November 2016. The stock had outperformed the market over the past 30 days till 19 December 2016, rising 11.98% compared with the 0.86% rise in the Sensex. The scrip also outperformed the market in past one quarter, falling 4.78% as against Sensexs 7.53% decline.

The small-cap company has equity capital of Rs 21.73 crore. Face value per share is Re 1.

Granules India announced that Granules OmniChem facility, a 50:50 joint venture company of Granules India and Ajinimoto OmniChem NV, located at Vizag, Andhra Pradesh completed its first inspection by US Food and Drugs Administration (USFDA) with seven observation. Granules OmniChem will respond to these observations within stipulated time period, the company said. This facility currently manufactures active pharmaceutical ingredient (API) intermediates, it added.

Granules Indias net profit rose 25.05% to Rs 33.50 crore on 0.49% growth in net sales to Rs 341.22 crore in Q2 September 2016 over Q2 September 2015.

Granules India produces finished dosages, pharmaceutical formulation intermediates and active pharmaceutical ingredients for customers in the regulated and semi-regulated markets.

Powered by Capital Market - Live News

KEI Industries gains after collaboration with Swiss firm
Dec 20,2016

The announcement was made after market hours yesterday, 19 December 2016.

Meanwhile, the BSE Sensex was up 28.24 points, or 0.11%, to 26,402.94.

On the BSE, so far 69,000 shares were traded in the counter, compared with average daily volumes of 1.10 lakh shares in the past one quarter. The stock had hit a high of Rs 127 and a low of Rs 122.80 so far during the day.

The stock hit a 52-week high of Rs 139.50 on 10 November 2016. The stock hit a 52-week low of Rs 86 on 29 February 2016. The stock had outperformed the market over the past 30 days till 19 December 2016, rising 4.17% compared with the 0.86% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 6.46% as against Sensexs 7.53% decline.

The small-cap company has equity capital of Rs 15.56 crore. Face value per share is Rs 2.

KEI Industries has signed a foreign technical collaboration agreement with Brugg Kabel AG, a Switzerland-based 116 years old group, to manufacture extra high voltage cables above 220 kilovolt (kV) and up to 400kV at its manufacturing plant / facility located at Chopanki in Rajasthan.

The above technical collaboration agreement will allow KEI complete know-how transfer which shall include design, manufacturing, testing, techniques, training of its manufacturing / design personnel in manufacturing of cables along with jointing techniques as also complete EHV system design (design/manufacture/installation/testing & commissioning) of EHV cables.

Net profit of KEI Industries rose 49.1% to Rs 22.90 crore on 2.1% rise in net sales to Rs 620.65 crore in Q2 September 2016 over Q2 September 2015.

KEI Industries is a cable manufacturing company. It offers high and low tension cables, control and instrumentation cables, house wires and stainless steel wires, and high-technology specialty cables.

Powered by Capital Market - Live News

GIPCO moves higher after signing PPAs with GUVNL
Dec 20,2016

The announcement was made after market hours yesterday, 19 December 2016.

Meanwhile, the S&P BSE Sensex was up 36.37 points or 0.14% to 26,410.69

On the BSE, 53,000 shares were traded on the counter so far as against the average daily volumes of 49,684 shares in the past one quarter. The stock had hit a high of Rs 102.80 and a low of Rs 99.85 so far during the day. The stock had hit a 52-week high of Rs 110.05 on 11 November 2016. The stock had hit a 52-week low of Rs 74.40 on 15 March 2016. The stock had outperformed the market over the past 30 days till 19 December 2016, rising 2.93% compared with the 0.86% rise in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 12.2% as against Sensexs 7.53% decline.

The small-cap power generation firm has equity capital of Rs 151.25 crore. Face value per share is Rs 10.

Gujarat Industries Power Company (GIPCO) said that the company has signed power purchase agreements (PPA) for a period of twenty five years with Gujarat Urja Vikas Nigam (GUVNL) for the entire 26 megawatts (MW) wind farm capacity of the Rojmal Wind Farm.

Gujarat Industries Power Companys net profit rose 32.66% to Rs 50.53 crore on 7.43% rise in total income to Rs 336.33 crore in Q2 September 2016 over Q2 September 2015.

Gujarat Industries Power Company is engaged in the business of electrical power generation.

Powered by Capital Market - Live News

Tata Coffee advances on plans to set up plant in Vietnam
Dec 20,2016

The announcement was made after market hours yesterday, 19 December 2016.

Meanwhile, the S&P BSE Sensex was up 20.70 points or 0.08% at 26,395.40.

On the BSE, 16,000 shares were traded on the counter so far as against the average daily volumes of 1.41 lakh shares in the past one quarter. The stock had hit a high of Rs 116.15 and a low of Rs 114.50 so far during the day.

The stock had a hit 52-week high of Rs 150.05 on 20 October 2016 and a 52-week low of Rs 81.70 on 17 February 2016. The stock had underperformed the market over the past one month till 19 December 2016, advancing 0.44% compared with the Sensexs 0.86% rise. The scrip had also underperformed the market over the past one quarter declining 8.38% as against the Sensexs 7.89% fall.

The small-cap company has equity capital of Rs 18.68 crore. Face value per share is Rs 1.

The latest decision from Tata Coffee to set up a plant in Vietnam will further strengthen the companys growth in the premium instant coffee segment. Instant coffee accounts for about 20% of the global coffee consumption with freeze dried instant coffee being the most premium.

The plant in Vietnam will serve Tata Coffees global customers with new product mixes of freeze dried coffee.

Tata Coffees Managing Director Sanjiv Sarin said that Vietnam offers an attractive business environment besides being the largest Robusta Coffee growing region. He further added that the plant will help the company to further expand its global footprint.

Tata coffees consolidated net profit rose 61.9% to Rs 44.65 crore on 8.5% decline in net sales to Rs 355.55 crore in Q2 September 2016 over Q2 September 2015.

Tata coffee is leading player in coffee business.

Powered by Capital Market - Live News

Wockhardt gains as Chikalthana plant gets GMP certificate from UK MHRA
Dec 20,2016

The announcement was made after market hours yesterday, 19 December 2016.

Meanwhile, the BSE Sensex was up 22.59 points, or 0.09%, to 26,397.29.

On the BSE, so far 86,000 shares were traded in the counter, compared with average daily volumes of 2.48 lakh shares in the past one quarter. The stock had hit a high of Rs 704 and a low of Rs 692.25 so far during the day.

The stock hit a 52-week high of Rs 1,647 on 13 January 2016. The stock hit a 52-week low of Rs 659 on 23 November 2016. The stock had underperformed the market over the past 30 days till 19 December 2016, falling 6.76% compared with the 0.86% rise in the Sensex. The scrip had also underperformed the market in past one quarter, falling 25.25% as against Sensexs 7.53% decline.

The mid-cap company has equity capital of Rs 55.27 crore. Face value per share is Rs 5.

Wockhardt said that UK Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed that general compliance with the principles and guidelines of Good Manufacturing Practice of the companys manufacturing unit at L-1, Chikalthana, Aurangabad. In view of this, the approval status of the said unit continues. Further, UK MHRA has considered the said manufacturing unit suitable for Risk based Inspection with reduced inspection frequency of 2 years from the existing inspection frequency of 1 year.

On a consolidated basis, net profit of Wockhardt declined 81.59% to Rs 17.02 crore on 13.41% decline in net sales to Rs 1064.69 crore in Q2 September 2016 over Q2 September 2015.

Wockhardt is a research based and technology intensive global pharmaceutical and biotechnology company.

Powered by Capital Market - Live News